Inventor
BLECH STEFAN
DE12 patents
⚠️ This page may combine multiple inventors who share the name “BLECH STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
10 patentsUS6972288B1Dec 6, 2005
4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
BOEHRINGER INGELHEIM PHARMA81 citations98
US6740651B2May 25, 2004
Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
BOEHRINGER INGELHEIM PHARMA90 citations98
US6656946B2Dec 2, 2003
Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
BOEHRINGER INGELHEIM PHARMA79 citations98
US6653305B2Nov 25, 2003
Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
BOEHRINGER INGELHEIM PHARMA93 citations98
US6627634B2Sep 30, 2003
Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
BOEHRINGER INGELHEIM PHARMA100 citations98
US6617329B2Sep 9, 2003
Aminoquinazolines and their use as medicaments
BOEHRINGER INGELHEIM PHARMA65 citations96
US6403580B1Jun 11, 2002
Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them
BOEHRINGER INGELHEIM PHARMA70 citations96
US6187780B1Feb 13, 2001
Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity
BOEHRINGER INGELHEIM PHARMA32 citations91
US6492377B1Dec 10, 2002
Imidazotriazolopyrimidines with adenosine-antagonistic activity
BOEHRINGER INGELHEIM PHARMA17 citations83
US8586608B2Nov 19, 2013
Quinazoline derivatives and pharmaceutical compositions containing them
BOEHRINGER INGELHEIM PHARMA1 citations63